Press
SURGE – US startup bags $32 million to blend cancer surgery and immunotherapy • Outsourcing Pharma
Media Coverage
|
20 July 2023
SURGE Therapeutics secures $32m to advance intraoperative immunotherapy • NS Healthcare
Media Coverage
|
20 July 2023
Immunotherapy during surgery? Surge Therapeutics nabs $32M to expand clinical plans after first dosing • Endpoints
Media Coverage
|
19 July 2023
SURGE – This Startup Just Raised $32 Million To Keep Cancers From Recurring After Surgery • Forbes
Media Coverage
|
19 July 2023
July 19 Quick Takes: Surge Therapeutics Inc. raised a $32 million series B round • Biocentury
Media Coverage
|
19 July 2023